Search Results 121-130 of 14759 for alt
Histologic evidence on a historical liver biopsy within 24 months of Screening consistent with NASH with fibrosis (no cirrhosis), and elevated ALT at Screening;.
Bilirubin >1.5xULN (isolated bilirubin >1.5xULN is acceptable if bilirubin is fractionated and direct bilirubin ULN ALT, AST, or ALP that does not meet the ...
ALT >2.5× upper limit of normal in the 12 months prior to study enrollment. Personal history of liver cirrhosis or malignancy. Estimated glomerular ...
Elevation in AST, ALT, Bilirubin or alkaline phosphatase more than five times the upper limit of normal. Participating Mayo Clinic locations. Study statuses ...
Serum ALT >450 U/L for males and >300 U/L for females (participants are eligible for re-screening if ALT levels fall to the range of eligibility). Treatment ...
In the absence of liver metastases, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) < 2.5 x ULN. If the patient has liver metastases, ALT ...
2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...
Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN]; Or total bilirubin [TBL] >2 x ULN; Or the ALT or Aspartate aminotransferase (AST) >3 x ULN ...
ALT and AST ≤2.5 × ULN; for patients with hepatic metastases, ALT and AST;; ≤ × ULN;; Calculated creatinine clearance (CL) ≥40 mL/min as determined by ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.